当前位置: 首页 > 期刊 > 《中国热带医学》 > 2006年第6期
编号:11024378
补骨胶囊治疗SLE患者骨质疏松症的作用机制
http://www.100md.com 《中国热带医学杂志》 2006年第6期
补骨胶囊;系统性红斑狼疮;骨质疏松,,补骨胶囊;系统性红斑狼疮;骨质疏松,1资料和方法,2结果,3讨论,参考文献:
     摘要:目的 研究补骨胶囊防治系统性红斑狼疮(SLE)患者长期使用糖皮质激素治疗并发骨质疏松或骨量减少的作用机制。 方法 66例SLE患者随机分为两组,治疗组(34例)采用糖皮质激素和补骨胶囊治疗,对照组(32例)采用糖皮质激素治疗,分析两组患者治疗前后血清血钙(Ca)、血磷(P)、血清碱性磷酸酶(ALP)和血甲状旁腺素(Parathyroid hormone,PTH)的变化,并对三角区(Ward's)等进行了骨密度(Bone mineral density,BMD)的测定。 结果 治疗组治疗前后血Ca、P、ALP和PTH差异无统计学意义,对照组血Ca和PTH的表达差异有统计学意义(P<0.01)。治疗组患者骨质疏松或骨量减少的发生率明显低于对照组(P<0.05)。 结论 补骨胶囊治疗SLE患者骨质疏松或骨量减少的机制可能是通过恢复SLE患者体内血Ca和PTH的平衡紊乱。

    关键词:补骨胶囊;系统性红斑狼疮;骨质疏松

    Mechanism of bugu capsule in treatment of osteoporosis in systemic lupus erythromatosus.

    CHEN Qiu-xia,SHI Jian-qiang,LI Chang-xing,et al.

    (Affiliated Hospital of Guangdong Medical College,Zhanjiang524000,Guangdong,P.R.China)

    Abstract:Objective To investigate the mechanism of Bugu capsules in the treatment of osteoporosis or bone loss in systemic lupus erythematosus(SLE)patients after long-term administration of glucocorticoid. Methods Sixty-six cases with SLEwere di-vided into two groups randomly.Treatment group consisted of34cases were treated with glucocorticoid and Bugu capsules and control group consisted of32cases were treated with glucocorticoid.All patients were evaluated by determination of bone mineral density(BMD)and related biochemical parameters such as serum calcium ......

您现在查看是摘要页,全文长 7515 字符